Altimmune Total Shareholders Equity 2011-2026 | ALT

Annual Total Shareholders Equity Altimmune

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
225 M	124 M	194 M	185 M	199 M	226 M	45.5 M	48.3 M	39.4 M	32.2 M	16.6 M	18.3 M	7.34 M	11.7 M	15.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
226 M	7.34 M	92.5 M

Quarterly Total Shareholders Equity Altimmune

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
186 M	161 M	142 M	124 M	133 M	153 M	173 M	194 M	150 M	168 M	168 M	185 M	205 M	195 M	185 M	199 M	209 M	241 M	246 M	226 M	226 M	226 M	226 M	45.5 M	45.5 M	45.5 M	45.5 M	48.3 M	48.3 M	48.3 M	48.3 M	39.4 M	39.4 M	39.4 M	39.4 M	32.2 M	32.2 M	32.2 M	19.5 M	43.1 M	16.6 M	16.6 M	16.6 M	18.3 M	18.3 M	18.3 M	18.3 M	7.34 M	7.34 M	7.34 M	7.34 M	11.7 M	11.7 M	11.7 M	11.7 M	15.9 M	15.9 M	15.9 M	15.9 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
246 M	7.34 M	89.4 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
ADC Therapeutics SA ADCT	166 M	$ 3.78	-	$ 105 M	Schweiz
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Akebia Therapeutics AKBA	32.6 M	$ 1.35	-2.17 %	$ 347 M	USA
Akari Therapeutics, Plc AKTX	28.3 M	$ 3.5	-21.7 %	$ 236 B	Britain
Aldeyra Therapeutics ALDX	44.3 M	$ 1.58	-4.82 %	$ 94.9 M	USA
Aligos Therapeutics ALGS	53.5 M	$ 8.36	4.89 %	$ 82.6 M	USA
Alnylam Pharmaceuticals ALNY	789 M	$ 330.71	3.72 %	$ 43.3 B	USA
ALX Oncology Holdings ALXO	26 M	$ 1.98	0.25 %	$ 106 M	USA
Amgen AMGN	8.66 B	$ 346.45	-0.43 %	$ 186 B	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Amneal Pharmaceuticals AMRX	-70.8 M	$ 12.37	-0.92 %	$ 3.88 B	USA
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Anika Therapeutics ANIK	212 M	$ 15.0	1.32 %	$ 220 M	USA
ANI Pharmaceuticals ANIP	404 M	$ 76.34	2.87 %	$ 1.47 B	USA
Annexon ANNX	212 M	$ 5.64	2.45 %	$ 875 M	USA
Aptorum Group Limited APM	21.1 M	$ 0.92	-1.11 %	$ 5.02 M	China
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Aprea Therapeutics APRE	12.4 M	$ 0.73	2.63 %	$ 4.77 M	USA
Aquestive Therapeutics AQST	-33.7 M	$ 4.15	0.48 %	$ 444 M	USA
Arcturus Therapeutics Holdings ARCT	214 M	$ 8.43	4.98 %	$ 231 M	Israel
Ardelyx ARDX	167 M	$ 6.08	2.27 %	$ 1.47 B	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Arcutis Biotherapeutics ARQT	189 M	$ 23.93	1.27 %	$ 3.04 B	USA
Arvinas ARVN	434 M	$ 11.11	2.4 %	$ 788 M	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Arrowhead Pharmaceuticals ARWR	466 M	$ 61.57	0.88 %	$ 8.24 B	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Assembly Biosciences ASMB	207 M	$ 30.01	3.43 %	$ 336 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Actinium Pharmaceuticals ATNM	7.83 M	$ 1.14	16.28 %	$ 35.6 M	USA
Atossa Therapeutics ATOS	39.4 M	$ 5.21	-2.89 %	$ 44.9 M	USA
Atara Biotherapeutics ATRA	-38.5 M	$ 5.03	0.7 %	$ 63.1 M	USA
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Aurinia Pharmaceuticals AUPH	581 M	$ 16.04	2.75 %	$ 2.16 B	Canada
Autolus Therapeutics plc AUTL	178 M	$ 1.42	0.35 %	$ 378 M	Britain
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	16.9 M	-	10.36 %	$ 9.8 M	USA